HRT Financial’s KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 KORE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,555
Closed -$3K 3435
2022
Q3
$3K Sell
27,555
-3,208
-10% -$908 ﹤0.01% 2635
2022
Q2
$17K Sell
30,763
-1,832
-6% -$1.16K ﹤0.01% 2629
2022
Q1
$30K Hold
32,595
﹤0.01% 2786
2021
Q4
$34K Buy
+32,595
New +$38.2K ﹤0.01% 2888

Other funds holding KORE.WS

HRT Financial's KORE.WS Position: Q4 2022 in Review

HRT Financial sold out of KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (KORE.WS) in Q4 2022, closing a stake of 27,555 shares — an estimated $3K sold.

HRT Financial first reported a position in KORE.WS in Q4 2021 and held it in 4 quarters. The position peaked at $34K in Q4 2021. 18 funds tracked by Wall St. Rank hold KORE.WS as of Q4 2022.

  • HRT Financial reported no remaining KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 27,555 KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $3K.
  • HRT Financial first reported a position in KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 4 quarters.
  • HRT Financial's KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $34K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.